5-Chloro-2-nitrobenzaldehyde

We are 5-Chloro-2-nitrobenzaldehyde CAS:6628-86-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Chloro-2-nitrobenzaldehyde
CAS.NO:6628-86-0
Synonyms:5-Chloro-2-nitrobenzaldehyde
5-chloro-2-nitro-benzaldehyde
3-chloro-6-nitrobenzaldehyde
6-nitro-3-chlorobenzaldehyde
4-Chloro-2-formylnitrobenzene
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 310.2±27.0 °C at 760 mmHg
Melting Point 65-69 °C(lit.)
Molecular Formula C7H4ClNO3
Molecular Weight 185.565
Flash Point 141.4±23.7 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.630
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ethychlozate(CAS:27512-72-7).

5-Chloro-2-nitrobenzaldehyde


Related News: From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.Methyl 2-methyl-3-nitrobenzoate CAS:59382-59-1 Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.2-(2-amino-4-bromophenyl)-5-bromoaniline CAS:136630-36-9 Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.decyl 2-methylprop-2-enoate CAS:3179-47-3 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.

Related Products
Product Name
2-Fluoro-6-iodobenzonitrile View Details
1-BROMO-2-FLUORO-4-IODOBENZENE View Details
2,6-Difluoro-3-nitrobenzonitrile View Details
1-[(4-nitrophenyl)methylsulfonyl]pyrrolidine manufacturer 2-(4-bromo-phenyl)-1(9)H-benzo[d]imidazo[1,2-a]imidazole manufacturer 1-methyl-3-methoxyoestra-1,3,5(10)-trien-17-one manufacturer 2-(3-Chloropropyl)-2,5,5-trimethyl-1,3-dioxane manufacturer Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate manufacturer